Precautionary recall of antidepressant medication due to manufacturing error
The MHRA has advised healthcare professionals to stop supplying the affected batch of Sertraline 100mg and return all remaining stock to their suppliers.
www.gov.ukHere’s the latest I can share based on available reporting up to now.
-
There have been several antidepressant recalls in recent years tied to manufacturing or dissolution issues, with some cases involving duloxetine (brand Cymbalta) and venlafaxine hydrochloride. For example, recalls in 2024 included duloxetine batches in the U.S. due to concerns about dissolution or potential contamination, prompting FDA notices and consumer advisories. These recalls typically classify risk levels (Class II for temporary or reversible health effects, or similar categorizations) and specify affected lot numbers, expiration dates, and distribution details.
-
In 2026, the UK’s MHRA issued a precautionary recall affecting a batch of sertraline 100 mg, advising the cessation of supply and return of stock, reflecting ongoing regulatory vigilance around antidepressant manufacturing quality.
-
News coverage of antidepressant recalls tends to emphasize: (1) how to check if your specific lot is affected (look for the recall notice, batch/lot numbers, and expiration date), (2) what to do if you have an affected product (do not take it, contact the pharmacy or manufacturer for guidance or replacement), and (3) potential health implications (often temporary or reversible if exposure is limited, with some recalls labeled Class II or similar).
If you want, I can:
- Narrow to a specific antidepressant (e.g., duloxetine, sertraline, venlafaxine) and pull the most recent recall notice and consumer steps.
- Check for any patient-facing guidance from the FDA or MHRA and summarize the exact actions for patients in Los Angeles.
Would you like me to focus on a particular medication or regulatory agency? I can also provide a quick checklist to verify whether your prescription might be affected and what to do next.